Find out how our comprehensive hematology test menu aids in diagnosis and treatment across a wide range of complex pediatric hematologic disorders.
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.
search - Mayo Clinic Laboratories
Search Results Site Search...
search - Mayo Clinic Laboratories
Search Results Site Search...
Lab discoveries fuel updates for autoimmune movement disorders test - Insights
Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...
Phage immunoprecipitation sequencing identifies previously unknown disease biomarkers - Insights
In Mayo Clinic’s Advanced Diagnostics Laboratory, there are dozens of projects underway at once to develop new technologies, discover novel findings, validate new tests, and support physicians in providing advanced patient care. For...
Revolutionizing Endometrial Cancer Diagnostics - Insights
Endometrial cancer affects thousands annually and ranks as the fourth most common cancer among women in the United States. At the forefront of innovative discoveries in endometrial cancer diagnostics are Mayo Clinic's Department of...
Leveraging technology to transform Anatomic Pathology - Insights
As Mayo Clinic’s Anatomic Pathology moves from traditional glass slides to digital images, the advance in technology is achieving clear benefits in collaboration, learning, and patient care.
How digital pathology provides faster answers - Insights
Almost four years ago, Mayo Clinic launched the Digital Pathology Program, a major pathology initiative. Phase 2 of this multi-phase rollout has recently been completed, which involved the implementation of cutting-edge digital equipment...
Modified two-tiered testing for Lyme disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).
A Mayo Clinic BioPharma Diagnostics engagement offers partners access to Mayo Clinic Laboratories’ robust library of hematology evaluations.
Mayo Clinic’s cardiac (CV) remote monitoring service uses the compact MoMe Kardia cardiac monitoring device that yields a continuous, 24/7 stream of a patient’s ECG and motion data, no matter their location. Any troubling or burgeoning...
Multiomics: A new model for identifying biomarkers to predict severe COVID-19 outcomes - Insights
In a groundbreaking study, Mayo Clinic investigators have developed a multiomic molecular method to predict clinical COVID-19 (SARS-CoV-2) outcomes better than traditional cytokines. Using a machine-learning-based prediction model, the team...
New high-resolution urine drug testing profile - Insights
Bringing together advanced testing technology, unparalleled expertise, and a patient-focused approach, Mayo Clinic Laboratories’ new high-resolution urine drug testing profile, ADMPU, evaluates for 22 drug classes including alcohol,...
An inside look at the state-of-the-art supports enabling invention - Insights
A web of innovation within Mayo Clinic Laboratories links research and test development with clinical practice, enabling for some of the world’s most pioneering methodologies. Underpinning this innovation network are unique supports that...
The Living Breast Biobank - Insights
This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.
Cytomegalovirus, or CMV, is a common cause of disease in the transplant population. In some patients who are diagnosed with CMV and are on antiviral treatment for infections, the virus may develop resistance to the drugs. This “Hot Topic”...
The Secrets of Cryoprecipitate: A Blood Banking Process - Insights
In this month’s “Hot Topic,” Jessie Swanson and Michelle Soland from the Component Laboratory will discuss the process improvement that helped decrease the standard cryoprecipitate dosage and the positive impact it has on patients.
Epic journey yields unique offering - Insights
The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.
Diagnostic ecosystem boosts access to timely Alzheimer's disease testing - Insights
Mayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer's disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The testing suite exemplifies Mayo Clinic...
Cross-laboratory collaboration accelerates gold-standard SRA testing - Insights
Utilizing testing capabilities of two separate laboratory facilities, Mayo Clinic Laboratories’ new serotonin release assay (SRA) is a gold-standard test supported by decades of clinical hematopathologic experience and advanced mass...
A novel testing approach for newly identified VEXAS syndrome - Insights
VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...
Synthesizing cardiovascular genetic test results into a unified diagnosis for the patient - Insights
For over two decades, Mayo Clinic has been at the forefront of cardiovascular (CV) genetic testing. The current test menu features 24 different panels that span over 300 genes linked to inherited cardiovascular disorders, many of which are...
Unveiling a novel hemoglobinopathy classification - Insights
In a recent discovery by Mayo Clinic Laboratories, a novel hemoglobinopathy category was identified and termed epsilon gamma thalassemia. The first instance of the disorder was found in 2017 when an obstetric patient underwent a routine...
Hematology Testing - Mayo Clinic Laboratories
Our comprehensive test menu has beencreated to aid in the diagnosis and treatmentselection across the full spectrum of hematologicdisorders.
Billing, Coding, and Payment Updates for 2023 - Insights
Skip to Content MayoACCESS MayoLINK...
Pathways Case Studies: January 2024 - Insights
Short, interactive case studies from Mayo Clinic physicians, scientists, and allied health staff.
Pathways Case Studies: August 2024 - Insights
Short, interactive case studies from Mayo Clinic physicians, scientists, and allied health staff
Pathways Case Studies: October 2024 - Insights
Short, interactive case studies from Mayo Clinic physicians, scientists, and allied health staff.
Pathways Case Studies: September 2024 - Insights
Short, interactive case studies from Mayo Clinic physicians, scientists, and allied health staff.
Newborn Screen Follow-up for Severe Combined Immunodeficiency Syndrome (SCID) [Algorithm] - Insights
The algorithm can be viewed here.
Specimen Shipment Alert: Jan. 30 - Insights
In close collaboration with our logistics providers, we have determined that clients can now safely send all specimens to Rochester now that temperatures have moderated. Thank you for your patience and understanding.
Hurricane Lee: Potential specimen delays - Insights
Hurricane Lee will be impacting the New England area and northeastern Canada this weekend. We are monitoring and tracking the situation with our logistics partners to minimize challenges. Your organization will be contacted directly by the...
Mayo Clinic monitoring rising avian influenza cases - Insights
In a post on Mayo Clinic’s News Network, Mayo Clinic’s director of Clinical Virology, Matthew Binnicker, Ph.D., explains the concern over a potential human-to-human outbreak of avian influenza and what’s being done at Mayo Clinic and...
Notice: New outgoing Mayo Lab Inquiry caller ID - Insights
Mayo Clinic Laboratories’ call center has a new outgoing caller ID number for any follow up client communications.
Thank you for your collaboration in 2023 - Insights
Mayo Clinic Laboratories is grateful for the opportunity to serve you and other healthcare professionals around the globe in providing critical answers and actionable insights.
Monitoring Hurricane Debby - Insights
As Hurricane Debby moves through the Southeast United States (Florida, Georgia, South Carolina, North Carolina, and Virginia), we continue to monitor and track the situation with our logistics partners to minimize challenges. Clients in the...
Billing, Coding, and Payment Updates for 2024 - Insights
Skip to Content MayoACCESS MayoLINK...
Building Blocks for a Successful Contact Center - Insights
Skip to Content MayoACCESS MayoLINK...
B-Lymphoblastic Leukemia/Lymphoma [Algorithm] - Insights
This algorithm can be viewed here.
Strategic Tech Initiatives in Lab Operations: Recipe(s) for Success - Insights
Skip to Content MayoACCESS MayoLINK...
MayoComplete next-generation sequencing: Transforming comprehensive cancer care - Insights
Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.
Progressive alliance advances science through patient-powered research - Insights
Tying together the expertise and curiosity of Mayo Clinic autoimmune neurology researchers with eager patients who have rare disease and are looking for answers, the innovative collaboration benefits both patients affected by MOGAD and...
Join us for Phlebotomy 2024: Pathways to Excellence - Insights
Registration is now open for Phlebotomy 2024: Pathways to Excellence, a virtual conference by Mayo Clinic Laboratories. This three-day event offers insights and techniques for managing burnout and ways to create a positive patient...
Mayo Clinic neuropathologist Caterina Giannini, M.D., Ph.D., received the American Association of Neuropathologists’ (AANP) award for Meritorious Contributions to Neuropathology during the AANP’s 98th annual meeting in June.
Register today for Classical Hematology 2023 - Insights
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference will also provide the latest...
Mayo Clinic Laboratories presents Classical Hematology 2023 - Insights
This conference will provide a comprehensive approach to the evaluation of frequently encountered blood count abnormalities, along with an update on the diagnosis and management of common and rare nonmalignant blood disorders. The...
Mayo Clinic Laboratories presents the 18th Bleeding and Thrombosing Diseases conference - Insights
This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. Informational presentations will be supplemented with panel discussions and case presentations, followed by...
Register today for the 18th Bleeding and Thrombosing Diseases conference - Insights
Get ready for the 18th Bleeding and Thrombosing Diseases conference! This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. It will take place Oct. 4–6, 2023, in...